SLC30A8 is aberrantly expressed in breast cancer and glioblastoma tumors, and decreased expression of SLC30A8 could contribute to the uncontrolled growth, proliferation, and tumor maintenance of glioblastoma multiforme cells56,57. Here, SLC30A8 is linked to neoplasm.